Business Context and Reporting Period
Crown Reserve Acquisition Corp. I is a Cayman Islands blank check company incorporated on April 29, 2025, formed to effect a business combination. This Form 10-Q covers the quarter ended September 30, 2025, and the period from inception through that date. As of the balance sheet date, the Company had not commenced principal operations and had no operating revenue. The Company consummated its Initial Public Offering (IPO) on November 10, 2025, subsequent to the reporting period.
Key Financial Metrics
| Metric | Value (as of Sept 30, 2025) |
|---|---|
| Total Assets | $530,147 |
| Cash and Cash Equivalents | $25,149 |
| Deferred Offering Costs | $504,998 |
| Total Liabilities | $504,998 |
| Promissory Note (Related Party) | $243,748 |
| Accrued Offering Costs | $261,250 |
| Shareholder's Equity | $25,149 |
| Net Income (3 Months Ended Sept 30) | $96 |
| Net Income (Inception to Sept 30) | $149 |
| Revenue | $0 (No operations) |
Material Changes and Subsequent Events
The most significant development occurred subsequent to the reporting period. On November 10, 2025, the Company consummated its IPO:
- Units Sold: 17,250,000 Units (including full exercise of the 2,250,000 unit over-allotment option) at $10.00 per unit.
- Gross Proceeds: $172,500,000.
- Private Placement: Simultaneously sold 375,000 Private Placement Units to the Sponsor at $8.00 per unit for $3,000,000.
- Trust Account: $172,500,000 was deposited into the Trust Account.
- Transaction Costs: Totaling $2,079,000 ($1,725,000 cash underwriting fee and $354,000 other costs).
As of September 30, 2025, the Company had no Class A shares outstanding. Following the IPO, 17,250,000 Class A shares were issued. The 562,500 Class B shares previously subject to forfeiture were retained by the Sponsor due to the full exercise of the over-allotment option.
Outlook, Risks, and Management Commentary
Liquidity and Capital Resources: Prior to the IPO, liquidity was funded by a $25,000 purchase of founder shares and a related-party promissory note of $243,748. Management believes the net proceeds from the IPO and private placement are sufficient to fund working capital needs for at least 12 months post-IPO. The Company expects to incur significant costs related to due diligence, legal, and accounting fees in searching for a target.
Business Combination Timeline: The Company must complete a business combination by November 10, 2026 (12 months from the IPO closing) or during any extension period. Failure to do so will result in liquidation and redemption of public shares.
Risks and Contingencies:
- Going Concern: While the IPO resolved immediate liquidity concerns, the Company has no assurance it will successfully complete a business combination.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025, due to the lack of formal internal control processes and segregation of duties prior to the IPO. Implementation is planned post-IPO.
- Redemption Rights: Public shareholders have the right to redeem shares for a pro rata portion of the Trust Account (initially $10.00 per share plus interest) upon the completion of a business combination.
Investor Verification Checklist
- IPO Closing Confirmation: Verify the final closing details and Trust Account balance via the Form 8-K filed on November 12, 2025.
- Trust Account Interest: Monitor the interest rate environment, as interest income is the only source of revenue prior to a business combination and affects the redemption value.
- Related Party Loans: Track the status of the $243,748 promissory note and any future "Working Capital Loans" from the Sponsor, which may be convertible into units.
- Internal Control Remediation: Review future filings for updates on the implementation of effective internal controls over financial reporting.
- Target Search Progress: Monitor for any announcements regarding substantive discussions with potential business combination targets.